These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32407995)

  • 21. [Hypercholesterolemia, from screening to treatment: Who, why and how to manage].
    Yelnik CM; Bruckert É
    Rev Med Interne; 2021 Oct; 42(10):707-713. PubMed ID: 33308860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.
    Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W
    Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolemia and cardiovascular disease in older individuals.
    Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
    Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.
    Vrablik M; Raslová K; Vohnout B; Blaha V; Satny M; Kyselak O; Vaclova M; Urbanek R; Maskova J; Soska V; Freiberger T
    Atherosclerosis; 2018 Oct; 277():355-361. PubMed ID: 30270071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.
    Rallidis LS; Liberopoulos EN; Vlachopoulos C; Skoumas I; Kolovou G; Anastasiou G; Dima I; Tousoulis D; Iliodromitis E
    Atherosclerosis; 2020 Sep; 309():67-69. PubMed ID: 32859385
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia.
    Ginsberg HN; Tuomilehto J; Hovingh GK; Cariou B; Santos RD; Brown AS; Sanganalmath SK; Koren A; Thompson D; Raal FJ
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):69-76. PubMed ID: 30734207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Hopkins PN; Toth PP; Ballantyne CM; Rader DJ;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S9-17. PubMed ID: 21600530
    [No Abstract]   [Full Text] [Related]  

  • 30. Familial hypercholesterolemia from children to adults.
    Ose L
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):289-93. PubMed ID: 12652097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
    Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A
    Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia.
    Gallo A; Charriere S; Vimont A; Chapman MJ; Angoulvant D; Boccara F; Cariou B; Carreau V; Carrié A; Bruckert E; Béliard S;
    Atherosclerosis; 2020 Aug; 306():41-49. PubMed ID: 32688103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.
    Turgeon RD; Barry AR; Pearson GJ
    Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study.
    Stefanutti C; Pang J; Di Giacomo S; Wu X; Wang X; Morozzi C; Watts GF; Lin J
    J Clin Lipidol; 2019; 13(4):608-617. PubMed ID: 31255589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
    Pojskic L; Pojskic B
    Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial hypercholesterolemia in children and adolescents].
    Lemale J; Tounian P
    Rev Prat; 2019 Nov; 69(9):1001-1004. PubMed ID: 32237625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features, diagnosis and frequency of familial hypercholesterolemia.
    Khachadurian AK
    Beitr Infusionsther; 1988; 23():26-32. PubMed ID: 2484779
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice.
    Vohnout B; Fábryová Ľ; Klabník A; Kadurová M; Bálinth K; Kozárová M; Bugáňová I; Sirotiaková J; Rašlová K
    Atherosclerosis; 2018 Oct; 277():323-326. PubMed ID: 30270066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.